Abrin immunotoxin: targeted cytotoxicity and intracellular trafficking pathway.
<h4>Background</h4>Immunotherapy is fast emerging as one of the leading modes of treatment of cancer, in combination with chemotherapy and radiation. Use of immunotoxins, proteins bearing a cell-surface receptor-specific antibody conjugated to a toxin, enhances the efficacy of cancer tre...
Main Authors: | Sudarshan Gadadhar, Anjali A Karande |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23472175/?tool=EBI |
Similar Items
-
Nanocarrier mediated intracellular delivery of neutralizing antibodies for the management of abrin lethality
by: Meenakshi Sundaram Kumar, et al.
Published: (2017-01-01) -
Mechanistic insights into the neutralization of cytotoxic abrin by the monoclonal antibody D6F10.
by: Shradha Bagaria, et al.
Published: (2013-01-01) -
Endoplasmic reticulum stress-mediated activation of p38 MAPK, Caspase-2 and Caspase-8 leads to abrin-induced apoptosis.
by: Ritu Mishra, et al.
Published: (2014-01-01) -
A Novel Humanized Anti-Abrin A Chain Antibody Inhibits Abrin Toxicity In Vitro and In Vivo
by: Jingyi Peng, et al.
Published: (2022-02-01) -
Mapping Immunodominant Antibody Epitopes of Abrin
by: Ron Alcalay, et al.
Published: (2020-04-01)